CHU Grenoble - pneumologie
Grenoble, France
University hospital in La Tronche
Av. des Maquis du Grésivaudan, 38700 La Tronche
About CHU Grenoble - pneumologie
The Grenoble Alpes University Hospital is a French teaching hospital built in 1974. With a total capacity of over 2 133 beds in 2020, it is the main hospital of Grenoble and Isère in France.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Intergroupe Francophone de Cancerologie Thoracique
9
Physio-Assist
3
Hoffmann-La Roche
2
Clinical Trials at CHU Grenoble - pneumologie
During the past decade, CHU Grenoble - pneumologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up
2005-01-01
2022-07-01
Completed
1,775
Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature
2005-04-01
2009-12-01
Completed
90
Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV
2004-11-01
2008-12-01
Completed
126
Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma
2006-09-01
2014-02-01
Completed
133
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Grenoble - pneumologie"
#1 collaborator was "Icadom" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Centre Hospitalier Universitaire de Besancon" with 1 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at CHU Grenoble - pneumologie
According to Clinical.Site data, the most researched conditions in "CHU Grenoble - pneumologie" are
"Carcinoma, Non-Small-Cell Lung" (3 trials), "Pulmonary Cystic Fibrosis" (2 trials), "Adenocarcinoma, Bronchiolo-Alveolar" (1 trials), "Bronchiectasis Adult" (1 trials) and "Hiv-positive" (1 trials). Many other conditions were trialed in "CHU Grenoble - pneumologie" in a lesser frequency.
Clinical Trials Intervention Types at CHU Grenoble - pneumologie
Most popular intervention types in "CHU Grenoble - pneumologie" are "Drug" (10 trials), "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (2 trials), "Gefitinib" (2 trials), "SIMEOX" (2 trials), "Alectinib" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CHU Grenoble - pneumologie
The vast majority of trials in "CHU Grenoble - pneumologie" are
14 trials for "All" genders.
Clinical Trials Status at CHU Grenoble - pneumologie
Currently, there are NaN active trials in "CHU Grenoble - pneumologie".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in CHU Grenoble - pneumologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CHU Grenoble - pneumologie, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".